What is the difference in access to anti-retroviral drugs, female between Congo, Democratic Republic of the and Myanmar?

0.0%, with Congo, Democratic Republic of the ahead.

How many years of comparable data are there for Congo, Democratic Republic of the and Myanmar?

25 years are reported by both, from 2000 to 2024.

Where does this data come from?

UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Congo, Democratic Republic of the vs Myanmar: Access to anti-retroviral drugs, female

Congo, Democratic Republic of the

78.0%

in 2024

Myanmar

78.0%

in 2024

Congo, Democratic Republic of the rank

60th

Myanmar rank

60th

Access to anti-retroviral drugs, female over time

Congo, Democratic Republic of the
Myanmar

How they compare

Congo, Democratic Republic of the currently reports 78.0% against 78.0% in Myanmar, a difference of 0.0%.

The two have swapped places 4 times across 25 shared years of data; in 2000 it was Myanmar ahead.

Congo, Democratic Republic of the ranks 60th and Myanmar ranks 60th of 141 countries.

Myanmar has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Congo, Democratic Republic of the	Myanmar	Difference	Ahead
2000s	2.0%	2.5%	0.5%	Myanmar
2010s	25.7%	39.2%	13.5%	Myanmar
2020s	70.2%	75.6%	5.4%	Myanmar

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, Congo, Democratic Republic of the or Myanmar?: Congo, Democratic Republic of the, at 78.0% against 78.0% in Myanmar as of 2024.
What is the difference in access to anti-retroviral drugs, female between Congo, Democratic Republic of the and Myanmar?: 0.0%, with Congo, Democratic Republic of the ahead.
How many years of comparable data are there for Congo, Democratic Republic of the and Myanmar?: 25 years are reported by both, from 2000 to 2024.
How do Congo, Democratic Republic of the and Myanmar rank globally for access to anti-retroviral drugs, female?: Congo, Democratic Republic of the ranks 60th and Myanmar ranks 60th of 141 countries.
Where does this data come from?: UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Congo, Democratic Republic of the vs Myanmar: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 13 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/congo-dem-rep/myanmar/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/congo-dem-rep/myanmar/">Congo, Democratic Republic of the vs Myanmar: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator: Access to anti-retroviral drugs, female (%)
Unit: %
Source: UNAIDS estimates
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 160 places, 3,925 data points, 2000–2024
Last refreshed: 04 September 2026

The percentage of adult females living with HIV who are receiving antiretroviral therapy.